Abstract
An important corollary to the recent advances in our understanding of the primary cause of Duchenne muscular dystrophy1–6, is the validation of genuine genetic homologues as animal models of the disease7,8 in which potential therapies can be tested. The persistent skeletal muscle necrosis that characterizes human Duchenne muscular dystrophy9 is also seen in the mdx mouse10–13 and is, in both, a consequence of a deficiency of dystrophin6,7, probably within the muscle fibres themselves14–16. As injected muscle precursor cells of one genotype can fuse with host muscle fibres of a different genotype and express the donor genes17,18, we decided to test grafts of normal muscle precursor cells to see if they could induce synthesis of dystrophin in innately dystrophin-deficient mdx muscle fibres. We show that injected normal muscle precursor cells can fuse with pre-existing or regenerating mdx muscle fibres to render many of these fibres dystrophin-positive and so to partially or wholly rescue them from their biochemical defect.
Similar content being viewed by others
References
Monaco, A. P. et al. Nature 323, 646–650 (1986).
Burghes, A. H. M. et al. Nature 328, 434–437 (1987).
Hoffman, E. P., Monaco, A. P., Feener, C. C. & Kunkel, L. M. Science 238, 347–350 (1987).
Koenig, M. et al. Cell 50, 509–517 (1987).
Koenig, M., Monaco, A. P. & Kunkel, L. M. Cell 53, 219–228 (1988).
Hoffman, E. H. et al. New Engl J. Med. 318, 1363–1368 (1988).
Hoffman, E. H., Brown, R. H. & Kunkel, L. M. Cell 51, 919–928 (1987).
Cooper, B. J. et al. Nature 334, 154–156 (1988).
Dubowitz, V., Sewry, C. A. & Fitzsimmons, R. B. in Muscle Biopsy, a Practical Approach 2nd edn (Baillière Tindall, London, Philadelphia and Toronto, 1985).
Bulfield, G., Siller, W. G., Wight, P. A. L. & Moore, K. J. Proc. natn. Acad. Sci. U.S.A. 81, 1189–1192 (1984).
Tanabe, Y., Esaki, K. & Nomura, T. Acta neuropath. 69, 91–95 (1986).
Carnwath, J. & Shotton, D. J. Neurol. Sci. 80, 39–54 (1987).
Coulton, G. R., Morgan, J. E., Partridge, T. A. & Sloper, J. C. Neuropath. appl. Neurobiol. 14, 53–70 (1988).
Thomson, W. H. S., Sweetin, J. C. & Elton, R. A. Nature 249, 151–152 (1974).
Hoffman, E. P., Hudecki, M. S., Rosenberg, P. A., Pollina, C. M. & Kunkel, L. M. Neuron. I, 411–420 (1988).
Morgan, J. E., Coulton, G. R. & Partridge, T. A. Muscle Nerve (in the press).
Watt, D. J., Morgan, J. E. & Partridge, T. A. Muscle Nerve 7, 741–750 (1984).
Morgan, J. E., Watt, D. J., Sloper, J. C. & Partridge, T. A. J. Neurol. Sci. 86, 137–147 (1988).
Billingham, R. E., Brent, L. & Medawar, P. B. Phil. Trans. R. Soc. B239, 1035–1036 (1956).
Cardasis, C. A. & Cooper, G. W. J. exp. Zool. 191, 347–358 (1975).
Watt, D. J., Morgan, J. E., Clifford, M. A. & Partridge, T. A. Anat. Embryol. 175, 527–536 (1987).
Morgan, J. E., Coulton, G. R. & Partridge, T. A. J. Muscle Res. Cell Motil. 8, 386–396 (1987).
Sugita, H. et al. Proc. Japan Acad. 64, 37–39 (1988).
Zubrzycka-Gaarn, E. E. et al. Nature 333, 466–469 (1988).
Bonilla, E. et al Cell 54, 477–452 (1988).
Watkins, S. C., Hoffman, E. P., Slayter, H. S. & Kunkel, L. M. Muscle & Nerve (submitted).
Morgan, J. E. J. Neurol. Sci. 85, 197–207 (1988).
Nudel, U., Robzyk, K. & Yaffe, D. Nature 331, 635–638 (1988).
Lev, A., Feener, C., Kunkel, L. M. & Brown, R. H. J. biol. Chem. 262, 15817–15819 (1987).
Law, P. K., Goodwin, T. G. & Li, H-J. Trans. Proc. 20, 1114–1119 (1988).
Law, P. K., Goodwin, T. G. & Wang, M. G. Muscle Nerve 11, 525–533 (1988).
Bradley, W. G. & Jenkinson, M. J. Neurol. Sci. 18, 227–247 (1973).
Peterson, A. C. Nature 248, 561–564 (1974).
Ontell, M. Hum. Path. 17, 673–682 (1986).
Webster, C. et al. Expl Cell Res. 174, 252–265 (1988).
Appleyard, S. T., Dunn, M. J., Dubowitz, V. & Rose, M. L. Lancet i, 361–363 (1985).
Ponder, B. A. J., Wilkinson, M. M., Wood, M. & Westwood, J. H. J. Histochem. Cytochem. 31, 911–919 (1983).
Watt, D. J., Morgan, J. E. & Partridge, T. A. Clin. exp. Immun. 55, 419–426 (1984).
Fletcher, J. A. J. clin. Path. 41, 410–414 (1988).
Lipton, B. H. & Schultz, E. Science 205, 1292–1294 (1979).
Kaprielian, Z. & Fambrough, D. M. Devl Biol. 124, 490–503 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Partridge, T., Morgan, J., Coulton, G. et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337, 176–179 (1989). https://doi.org/10.1038/337176a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/337176a0
- Springer Nature Limited
This article is cited by
-
Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy
EMBO Molecular Medicine (2024)
-
In vitro-generated human muscle reserve cells are heterogeneous for Pax7 with distinct molecular states and metabolic profiles
Stem Cell Research & Therapy (2023)
-
Systemic cell therapy for muscular dystrophies
Stem Cell Reviews and Reports (2021)
-
Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
Biological Research (2020)
-
In vivo stem cell tracking using scintigraphy in a canine model of DMD
Scientific Reports (2020)